EPO program (MedExGen)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameEPO program (MedExGen)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionTyrosine-protein kinase JAK2 modulators
TargetsTyrosine-protein kinase JAK2
Therapy Area/IndicationsAnemiaUremiaRenal Insufficiency
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMedexgen Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMedexgen Co Ltd
Active IndicationsN/A
Inactive IndicationsAnemiaUremiaRenal Insufficiency

Other Information

ATC CodeN/A
Related LinksN/A